Home
About
Overview
Sharing Data
ORCID
Help
History (5)
American Society of Clinical Oncology Statement: Biosimilars in Oncology.
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons.
Pathophysiology of ovarian steroid secretion in polycystic ovary syndrome.
TCF-1: a maverick in T cell development and function.
The Importance of Definitive Trials: The VIXIE Trial.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
American Society of Clinical Oncology Statement: Biosimilars in Oncology.
American Society of Clinical Oncology Statement: Biosimilars in Oncology. J Clin Oncol. 2018 04 20; 36(12):1260-1265.
View in:
PubMed
subject areas
Adolescent
Antineoplastic Agents
Biosimilar Pharmaceuticals
Humans
Legislation, Drug
United States
authors with profiles
Richard Schilsky